Definition
Osteoporosis, or brittle bone disease, is a disease
characterized by low bone mass and architectural changes
in bone tissue, leading to bone fragility and an increased
risk of fractures (broken bones).
Prevalence
Osteoporosis is a major public health threat for more
than 28 million Americans. While osteoporosis is often
thought of as an older person's disease, it can strike
at any age. In 2002 more than 10 million individuals,
8 million American women and 2 million men already had
the disease and over 18 million more have low bone mass,
putting them at risk of developing osteoporosis. 1
in 2 women and 1 in 8 men over the age of 50 will have
an osteoporosis-related fracture in their lifetime.
Osteoporosis
is responsible for more than 1.5 million fractures annually,
including:
· 300,000
hip fractures.
· 700,000
vertebral fractures.
· 250,000
wrist fractures.
· 300,000
fractures at other sites.
80% of
those affected by osteoporosis are women. Women can
lose up to 20% of their bone mass in the 5-7 years following
menopause, making them more susceptible to osteoporosis.
Osteoporosis,
however, is not confined to white and asian individuals.
In fact, 10% of African-American women over the age
of 50 have osteoporosis and an additional 30% have low
bone density. Significant risk has been reported in
people of all ethnic backgrounds.
Cost
The estimated national direct expenditures (hospitals
and nursing homes) for osteoporotic and associated fractures
was $13.8 billion in 1995 ($38 million each day) and
the cost is rising. Expenditures for the disease are
expected to exceed $60 billion by the year 2030.
Symptoms
Osteoporosis is often called the "silent disease" because
bone loss occurs without symptoms. People may not know
that they have osteoporosis until their bones become
so weak that a sudden strain, bump, or fall causes a
fracture(broken bone).
Collapsed
vertebrae (vertebral fractures) may initially be felt
or seen in the form of severe back pain, loss of height,
or spinal deformities such as kyphosis or stooped posture.
Risk
Factors
Certain people are more likely to develop osteoporosis
than others. The following risk factors have been identified:
· Being
female.
· Thin
and/or small frame.
· Advanced
age.
· A family
history of osteoporosis.
· Being
postmenopausal, including early or surgically induced
menopause.
· Abnormal
absence of menstrual periods (amenorrhea for more than
12 months).
· Anorexia
nervosa or bulimia.
· A diet
low in calcium.
· Use
of certain medications, such as corticosteroids and
anticonvulsants.
· Low
testosterone levels in men.
· An
inactive lifestyle.
· Cigarette
smoking.
· Excessive
use of alcohol.
· Being
Caucasian or Asian, although African Americans and Hispanic
Americans are at significant risk as well.
Detection
Specialized tests called bone density tests can measure
bone density in various sites of the body. A bone density
test can:
·Detect
osteoporosis before a fracture occurs.
· Predict
your chances of fracturing in the future.
· Determine
your rate of bone loss and/or monitor the effects of
treatment if the test is conducted at intervals of a
year or more.
Prevention
By about age 20, the average woman has acquired 98%
of her skeletal mass. Building strong bones during childhood
and adolescence can be the best defense against developing
osteoporosis later.
There
are four steps to prevent osteoporosis. No one step
alone is enough to prevent osteoporosis, but all four
may. They are:
· A balanced
diet rich in calcium and vitamin D.
· Weight-bearing
exercise.
· A healthy
lifestyle with no smoking or excessive alcohol intake.
· Bone
density testing and medication and when appropriate.
Fractures
The most typical sites of fractures related to osteoporosis
are the hip, spine, wrist, and ribs, although the disease
can affect any bone in the body. Although women suffer
twice as many hip fractures as men, men have worse outcomes
after a hip fracture.
Over
30% of men will die in the first year after a hip fracture.
An average of 24% of all hip fracture patients die in
the year following their fracture.
A woman's
risk of hip fracture is equal to her combined risk of
breast, uterine and ovarian cancer. In 1991, about 300,000
Americans age 45 and over were admitted to hospitals
with hip fractures. Osteoporosis was the underlying
cause of most of these injuries. One-fourth of those
who were ambulatory before their hip fracture require
long-term care afterward. White women 65 or older have
twice the incidence of fractures as African-American
women.
Medications
Although there is no cure for osteoporosis, the following
medications are approved by the FDA for postmenopausal
women to either prevent and/or treat osteoporosis:
· Estrogens
(brand names such as Premarin®, Ogen®, Estrace®, Estraderm®
and Estratab®, Prempro®, and others)
· Alendronate
(brand name Fosamax®) is also approved as a treatment
for men
· Calcitonin
(brand name Miacalcin®)
· Raloxifene
(brand name Evista®)
· Risedronate
(brand name Actonel®)
· Alendronate
is approved for treatment of glucocorticoid-induced
osteoporosis in men and women. Risedronate is approved
for prevention and treatment of glucocorticoid-induced
osteoporosis in men and women.
Treatments
under investigation include sodium fluoride; vitamin
D metabolites; parathyroid hormone; and other bisphosphonates
and SERMs.
|